Overview
Xingxin Li practices in Tianjin, China. Li is rated as an Advanced expert by MediFind in the treatment of Hereditary Spherocytosis. Their top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Cold Hemoglobinuria, and Paroxysmal Nocturnal Hemoglobinuria (PNH).
Their clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hereditary Spherocytosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Aplastic AnemiaLi isDistinguished. Learn about Aplastic Anemia.
- Advanced
- AnemiaLi isAdvanced. Learn about Anemia.
- Autoimmune Hemolytic Anemia
- Hereditary Spherocytosis
- Paroxysmal Cold Hemoglobinuria
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Sideroblastic Anemia
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Childhood Acute Myeloid Leukemia
- Congenital Afibrinogenemia
- Congenital Hemolytic Anemia
- DysfibrinogenemiaLi isExperienced. Learn about Dysfibrinogenemia.